• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Biogen Idec, WPI to develop programs for BETC

Biogen Idec, WPI to develop programs for BETC

May 31, 2013
CenterWatch Staff

Global biotechnology company Biogen Idec has signed a collaboration agreement with Worcester Polytechnic Institute (WPI) to develop and deliver programs at the university’s Biomanufacturing Education and Training Center (BETC) of Worcester, Mass.

Biogen Idec joins AbbVie (formerly Abbott Laboratories), Bristol-Myers Squibb, and Shire Human Genetic Therapies as affiliates of the BETC. Leaders from these companies collaborate with the BETC team to develop customized curricula and programs that support their specific business needs. Along with WPI life sciences faculty members and BETC subject-matter experts, professionals from partner companies will serve as instructors and mentors for students enrolled in non-proprietary programs at the BETC.

The first Biogen Idec program, a two-week course for 20 of its employees, began May 20 as the inaugural corporate class run at the BETC.

“Working with an academic institution like WPI greatly expands the tools we have to develop and train our workforce,” said Ed Goodreau, vice president of manufacturing at Biogen Idec. “The modern and relevant facility at WPI gives staff both knowledge and hands-on experience that they can bring back to our site for immediate impact.”

The BETC is located in the newest building at WPI’s Gateway Park. With large- and small-scale bioprocessing areas, support labs and classrooms, the center has industry-standard process areas for equipment preparation, buffer and media preparation, fermentation and cell culture, product capture, purification and analytics.

“Collaborating with industry to advance technologies and economic opportunities has been the hallmark of WPI since its founding,” said Stephen Flavin, WPI’s vice president for academic and corporate development. “The blending of academic and industrial expertise that we are creating at the BETC will help serve students and biotechnology companies throughout the region.”

 The creation of the BETC enhances WPI's presence in the life sciences; over the past eight years, the university has invested more than $110 million in life sciences education, research and infrastructure. These investments have come in the form of new faculty, the up-to-date technology, lab space and supporting facilities. 

“Biogen Idec’s commitment to our center, like that of our other partners, exemplifies the mission of the BETC, which is to deliver customized and relevant programs that help companies achieve their economic objectives and fulfill their commitments to their patients,” said Anthony Mangano, associate dean of corporate and professional education at WPI.

 

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing